Therapeutic usefulness of sentinel lymph node biopsy in patients with melanoma;Utilidad terapéutica directa de la biopsia del ganglio centinela en pacientes con melanoma

Medicina Clinica

Volumn 126, Issue 4, 2006, Pages 135-136

  Ferrándiz, Carlos ^a   Mangas, Cristina ^a  

^a HOSPITAL UNIVERSITARI GERMANS TRIAS I PUJOL   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

CANCER GROWTH; CANCER PATIENT; DIAGNOSTIC VALUE; EDITORIAL; HUMAN; HUMAN TISSUE; LYMPH NODE METASTASIS; LYMPHADENECTOMY; MELANOMA; MICROMETASTASIS; MORBIDITY; PROGNOSIS; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SENTINEL LYMPH NODE BIOPSY;

EID: 33644504212     PISSN: 00257753     EISSN: None     Source Type: Journal    
DOI: 10.1157/13084028     Document Type: Editorial

References (23)

1. Balch CM, Buzaid AC, Soong SJ, Atkins MB, Cascinelli N, Coit DG, et al. Final version of the American Joint Committee on Cancer staging system for cutaneous melanoma. J Clin Oncol. 2001;19:3635-48.
2. Gershenwald JE, Thompson W, Mansfield PF, Lee JE. Multi-institutional melanoma lymphatic mapping experience: the prognosis value of sentinel lymph node status in 612 stage I or II melanoma patients. J Clin Oncol. 1999;17:976-83.
3. Wagner JD, Corbett L, Park HM, Davidson D, Coleman JJ, Havlik RJ, et al. Sentinel lymph node biopsy for melanoma: experience with 234 consecutive procedures. Plast Reconstr Surg. 2000;105:1956-66.
4. Balch CM, Soong SJ, Gershenwald JF, Thompson JF, Reintgen DS, Cascinelli N, et al. Prognostic factors analysis of 17.600 melanoma patients: validation of the American Joint Committee on Cancer melanoma staging system. J Clin Oncol. 2001;19:3622-34.
5. Rex J, Paradelo C, Mangas C, Hilari JM, Fernández-Figueras MT, Fraile M, et al. A Single-institutional experience in the management of patients with clinical stage I and II cutaneous melanoma. Results of the sentinel lymph node biopsy in 240 cases. Dermatol Surg [en prensa].
6. Eedy DJ. Introducing controversies in dermatology: sentinel nymph node biopsy for cutaneous melanoma- a useful technique or a waste of time? Br J Dermatol. 2004;151:267-8.
7. Schmid-Wendtner MH, Baumert J, Schmidt M, Konz B, Holzel D, Plewig G, et al. Late metastases of cutaneous melanoma: an analysis of 31 patients. J Am Acad Dermatol. 2000;43:605-60.
8. Kuo CT, Hoon DS, Takeuchi H, Turner R, Wang HJ, Morton DL, et al. Prediction of disease outcome in melanoma patients by molecular analysis of paraffin-embedded sentinel lymph nodes. J Clin Oncol. 2003;21: 3566-72.
9. Li W, Stall A, Shivers SC, Lin J, Haddad F, Messina J, et al. Clinical relevance of molecular staging for melanoma: comparison of RT-PCR and immunohistochemistry staining in sentinel lymph nodes of patients with melanoma. Ann Surg. 2000;231:795-803.
10. Bostick PJ, Morton DL, Turner RR, Huynh KT, Wang HJ, Elashoff R, et al. Prognostic significance of occult metastases detected by sentinel lymphadenectomy and reverse transcriptase-polymerase chain reaction in early-stage melanoma patients. J Clin Oncol. 1999;17:3238-44.
11. Shivers SC, Wang X, Li W, Joseph E, Messina J, Glass LF, et al. Molecular staging of malignant melanoma correlation with clinical outcome. JAMA. 1998;280:1410-5.
12. Pizarro A. La biopsia del ganglio centinela desde una perspectiva inmunológica: ¿optimismo prematuro? Actas Dermosifiliogr. 2003;94:60-2.
13. Davids V, Kidson SH, Hanekom GS. Accurate molecular detection of melanoma nodal metastases: an assessment of multimarker assay specificity, sensitivity, and detection rate. Mol Pathol. 2003;56:43-51.
14. Morton DL, Hoon DS, Cochran AJ, Turner RR, Essner R, Takeuchi H, et al. Lymphatic mapping and sentinel lymphadenectomy for early-stage melanoma: therapeutic utility and implications of nodal microanatomy and molecular staging for improving the accuracy of detection of nodal micrometastases. Ann Surg. 2003;238;538-49.
15. Gadd MA, Cosimi AB, Yu J, Duncan LM, Yu L, Flotte TJ, et al. Outcome of patients with melanoma and histologically negative sentinel lymph nodes. Arch Surg. 1999;134:381-7.
16. Morton DL, Cochram AJ. The case for lymphatic mapping and sentinel lymphadenectomy in the management of primary melanoma. Br J Dermatol. 2004;151:308-19.
17. Meier F, Will S, Ellwanger U, Schlagenhauff B, Schittek B, Rassner G, et al. Metastatic pathways and time courses in the orderly progression of cutaneous melanoma. Br J Dermatol. 2002;147:62-70.
18. Veronesi U, Adamus J, Bandier DC, Brennhovd O, Coceres E, Cascinelli N, et al. Delayed regional lymph nodes dissection in stage I melanoma of the skin of the lower extremities. Cancer. 1982;49:2420-30.
19. Cascinelli N, Morabito A, Santinami M, MacKie RM, Belli F. Immediate or delayed dissection of regional nodes in patients with melanoma of the trunk: a randomised trial. Lancet. 1998;351:793-6.
20. Sim FH, Taylor WF, Pritchard DJ, Soule EH. Lymphadenectomy in the management of stage I melanoma: a prospective randomised study. Mayo Clinic Proc. 1986;61:697-705.
21. Balch CM, Soong SJ, Bartolucci AA, Urist MM, Karakousis CP, Smith TJ, et al. Efficay of an elective regional lymph node dissection of 1-4 mm thick melanomas for patients 60 years of age and younger. Ann Surg. 1996;224:255-66.
22. Shen J, Wallace AM, Bouvet M. The role of sentinel node biopsy for melanoma. Semin Oncol. 2002;29:341-52.
23. Paradelo C, Fraile M, Ferrándiz C, Alastrue A, Biagatá X. La linfoescintigrafía en el estudio de los patrones de drenaje linfático en pacientes con melanoma maligno. Med Clin (Barc). 1999;113:281-4.